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Abstract
Background: Indoor residual spraying (IRS) is widely used for malaria transmission control in sub-Saharan Africa. Resistance
to pyrethroids in the mosquito Anopheles gambiae is a growing problem. There is an urgent need to develop long-lasting
alternative insecticides to reduce selection pressure for pyrethroid resistance and to provide control with a single IRS
application in countries with long transmission seasons.
Methods: Two capsule suspension formulations (CS) of the organophosphate pirimiphos methyl were evaluated as IRS
treatments in experimental huts in an area of Benin where the mosquitoes Anopheles gambiae and Culex quinquefasciatus
are resistant to pyrethroids but susceptible to organophosphates. The CS formulations were tested alongside an
emulsifiable concentrate (EC) formulation of pirimiphos methyl and a CS formulation of the pyrethroid lambdacyhalothrin.
Results: The two CS formulations of pirimiphos methyl gave prolonged control of An. gambiae and Cx. quinquefasciatus. In
cement huts application rates of 0.5 g/m2 induced high mortality of An. gambiae for almost a year: overall mortality rates
87% (95% CI 82–91%) and 92% (95% CI 88–94%). In mud huts application rates of 1 g/m2 induced high mortality of An.
gambiae for 10 months: overall mortality rates 75% (95% CI 69–81%) and 76% (95% CI 68–83%). The EC formulation of
pirimiphos methyl failed to control An. gambiae two months after spraying. The pyrethroid lambdacyhalothrin
demonstrated prolonged residual activity in bioassay tests but failed to control pyrethroid resistant An. gambiae that
entered the huts. Pirimiphos methyl CS was highly active against Culex quinquefasciatus and gave control for 10 months in
cement huts and 6 months in mud huts.
Conclusion: Pirimiphos methyl CS (Actellic 300 CS) applied at 1 g/m2 shows great promise for providing prolonged control
of pyrethroid-resistant An gambiae and for delaying pyrethroid resistance. An alternative to DDT, giving year-round
transmission control in sub-Saharan Africa is now a realistic prospect.
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Background
Malaria control based on long-lasting insecticidal nets (LLINs)
and indoor residual spraying (IRS) is being scaled up across sub-
Saharan Africa with support from the Global Fund (GFATM), the
President’s Malaria Initiative (PMI), the UK Department for
International Development and national governments [1]. In areas
of seasonal transmission, prone to epidemics, IRS has the
advantage of protecting entire populations at risk [2,3]. In
holendemic areas of more stable transmission two or more spray
rounds of IRS may be required to cover the full transmission
season [4,5]. Spiralling costs of recurrent campaigns may make
IRS with conventional formulations harder to justify or sustain [6].
Of the residual insecticides approved by WHO the longest lasting
is DDT [2]. While the organophosphate, carbamate and
pyrethroid classes of insecticide are more acceptable environmen-
tally they are more expensive per unit area sprayed and shorter
lived than DDT [2,7]. Development of safer, more residual
insecticides is paramount to future malaria control. Reformulation
of WHO approved insecticides from the existing portfolio of
insecticides offers the most pragmatic solution [8]. Microencap-
sulation of pyrethroids and organophosphate insecticides is both
feasible and economic and can extend the residual life of
insecticides when applied to cement or mud plastered rooms [9–
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11]. With the alarming increase in pyrethroid resistance reported
from many endemic African countries [12–17], alternative
insecticides from non-pyrethroid classes require urgent develop-
ment, evaluation, approval and registration.
Pirimiphos-methyl is an organophosphate which in early field
trials of an emulsifiable concentrate formulation (EC) demonstrat-
ed high level but short lived activity against anophelines and
culicines [18–20]. The manufacturer of pirimiphos methyl,
Syngenta, has recently developed microencapsulated formulations
(CS) in response to the need to control pyrethroid resistant strains
with a long lasting effect.
We report on an evaluation of pirimiphos methyl for indoor
residual treatment conducted in experimental huts in southern
Benin. The efficacy of two capsule suspension formulations of
pirimiphos methyl (Actellic CS, Basle, Switzerland) was compared
to a standard emulsifiable concentrate formulation (Actellic 50EC,
Basle, Switzerland) and to the pyrethroid lambdacyhalothrin (Icon
10CS, Basle, Switzerland) in an area where Anopheles gambiae and
Culex quinquefasciatus are difficult to control with pyrethroids or
DDT owing to resistance [21,22].
Materials and Method
Study Sites and Experimental Huts
The Akron field site is situated in a horticultural area on the
outskirts of Porto Novo, the administrative capital of Benin. The
site provides permanent breeding of pyrethroid resistant Anopheles
gambiae M form, which contains kdr and metabolic resistance
mechanisms [23], 2008). Culex quinquefasciatus is also abundant and
is resistant to pyrethroids and DDT [24]. The experimental huts
are made of concrete bricks, with roofs of corrugated iron, ceilings
lined with woven palm matting on the interior surface, and walls
coated with cement/sand or mud/sand plaster mixes [25]. Each
hut stands on a concrete base surrounded by a narrow moat to
exclude scavenging ants. Entry of mosquitoes occurs via four
window slits, 1 cm wide, located on three sides of the hut.
Mosquitoes exit into a verandah trap projecting from the fourth
side.
Insecticide Treatments
The insecticides produced by Syngenta were:
N pirimiphos methyl B 30% CS
N pirimiphos methyl BM 30% CS
N pirimiphos methyl 50% EC
N lambdacyhalothrin 10% CS
The following treatments and target application rates were
compared in 12 experimental huts, some with cement plastered
walls, others with dried mud plastered walls, at the Akron site:
N pirimiphos methyl B CS, 0.5 g/m2 (one mud and one cement
walled hut)
N pirimiphos methyl BM CS, 0.5 g/m2 (one mud and one
cement walled hut)
N pirimiphos methyl B CS, 1 g/m2 (one mud and one cement
walled hut)
N pirimiphos methyl BM CS, 1 g/m2 (one mud and one cement
walled hut)
N pirimiphos methyl EC, 1 g/m2 (one mud and one cement
walled hut)
N lambdacyhalothrin CS, 0.03 mg/m2 (one cement walled hut)
N unsprayed control (one cement walled hut)
Hut interior surfaces were sprayed with an aqueous solution of
insecticide applied using a Hudson XPert compression sprayer to
the walls and the palm thatch ceilings. Spraying was completed on
16 April 2009. The trial started 3 days later and ran for 12 months.
Trial Procedure
The trial followed WHO Pesticide Evaluation Scheme proce-
dures for IRS [25]. Adult volunteers of 18 years or older were
selected as volunteers by lot from the local village to sleep in the
huts overnight. Volunteers were provided with chemoprophylaxis
and the risks of malaria were explained. Written informed consent
was obtained from all volunteer sleepers and documented.
Volunteers were given basic remuneration for participating in
the study. It was explained they had the right to withdraw to
withdraw from the trial at any time without penalty.
Each treatment was dedicated to a particular hut. Volunteer
sleepers rotated at random between huts, spending one night in
each hut during the weekly rotation. Sleepers were interviewed
individually using a questionnaire for possible adverse effects due
to insecticide; this was done daily during the first week, weekly
during the first month, and each month during the study year.
Responses were documented for further analysis. Any volunteer
showing adverse effect or sign of fever was referred to a local
physician and, if malaria was confirmed, treated with Co-artem
(artemether/lumefantrine, Novartis Pharmaceuticals corporation,
USA).
Each morning mosquitoes were collected from the verandahs
and rooms of huts and recorded as fed or unfed and dead or alive.
Live mosquitoes were provided with 10% glucose solution and
held for 24 h before scoring final mortality.
The trial protocol and consent form obtained approval from the
ethical committees of LSHTM (application approval number
5256) and Ministry of Health, Cotonou, Benin MOH ethics
committees.
The efficacy of each treatment was expressed in terms of:
– Exiting rates: proportion of mosquitoes exiting and trapped in
the verandah of a treated hut relative to the proportion in the
control hut.
– Blood-feeding inhibition: proportion of mosquitoes that were
blood fed in sprayed huts relative to the proportion in control
huts.
– Mortality: proportion of mosquitoes found dead after 24 h
holding time.
Residual Activity
Each month of the trial the residual activity of each treatment
on walls and ceilings was monitored by means of bioassay using
WHO cone tests. The insecticide-susceptible An. gambiae Kisumu
was used for this purpose, with exposure of 30 min and 24 h
recovery as per WHO guideline [25].
Species and Resistance Characterisation
Samples of An. gambiae s.l. reared from larval collections near
the trial site were identified to species using PCR [26] and to
molecular form using PCR RFLP [27].
WHO test kits lined with test papers treated with pirimiphos-
methyl and deltamethrin in silicon oil were used to determine
susceptibility of An. gambiae and Cx. quinquefasciatus females reared
from larval collections [28]. Batches of unfed females, aged 2–5
days, were exposed to test papers for 1 h and mortality rates were
recorded after 24 h. A discriminating concentration of pirimiphos-
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methyl which would kill 100% of susceptible insects was
established using a 0.125–1.0% concentration range.
PRC diagnostic test for detection of kdr mutations was carried
out on An. gambiae and Cx. quinquefasciatus mosquitoes as described
by Martinez-Torres et al. [29]. The PCR-RFLP diagnostic test
was used to detect the presence of the Ace.1R G119S mutation as
described by Weill et al. [30].
Data Analysis
The experimental hut data were entered in Excel and
transferred to STATA 6.0 software for analysis. The outcomes
of interest were the proportions of each species dying, blood-
feeding, and exiting a treatment over time. Logistic regression for
grouped data was used to estimate the outcomes between
treatments, comparing results for formulation, dosage, substrate
treated and period after treatment, with adjustment for clustering
by day and for variation between individual sleepers. The decay of
treatments over time in residual bioassay tests were analysed using
grouped logistic regression comparing percentage mortality at
intervals after spraying.
Results
Efficacy of IRS Against An. gambiae and Cx.
quinquefasciatus after 12 Months
Huts with cement walls. Table 1 shows the entomological
outcomes for An. gambiae and Cx. quinquefasciatus in huts with
cement lined walls. Owing to a potential hut position effect
(identified by the differences in number of mosquitoes collected
from individual huts during preliminary mosquito collections) and
the inability to rotate IRS treatments between huts, it was not
possible to interpret numbers of mosquitoes entering the huts in
terms of treatment effects. Overall there were fewer mosquitoes
entering the pirimiphos methyl huts than untreated control or
lambdacyalothrin huts but no inference can be drawn because
treatment induced deterrence cannot be distinguished from
differential attractiveness due to site position.
The proportions of An. gambiae and Cx. quinquefasciatus exiting
into the verandahs of IRS treated huts by dawn were not
significantly different to the proportions exiting the untreated
control huts; the only exception was the higher proportion of An.
gambiae exiting the lambdacyhalothrin-treated hut (p = 0.02)
(table 1).
Blood-feeding rates of An. gambiae ranged from 91 to 95% and
those of Cx. quinquefasciatus ranged from 71 to 78% across
treatments. Because mosquitoes tend not to alight on treated
walls or ceilings until after feeding, the IRS treatments tended not
to affect blood feeding rates which, consequently did not differ
between treatments.
In the cement walled huts the percentage mortality of An.
gambiae was 88% for the 0.5 g/m2 and 90% for the 1.0 g/m2
applications of pirimiphos methyl CS B. In the pirimiphos methyl
CS BM sprayed hut, mortality was 92% for the 0.5 g/m2 and 95%
for 1.0 g/m2 applications. The differences in mortality between
low and high application rates were not significant for either the
pirimiphos methyl B or BM variants but overall the BM
treatments killed significantly higher proportions of An. gambiae
than did the B treatments (p,0.05) (table 1). Mortality rates of An.
gambiae exposed to lambdacyhalothrin CS (22%) and pirimiphos
methyl EC (26%) treatments were much lower than with the
pirimiphos methyl CS treatments (p = 0.01).
The mortality of Cx. quinquefasciatus was consistently lower than
An. gambiae mortality across all treatments. Nevertheless, over 12
months of the trial, more than 50% of the Cx. quinquefasciatus
entering the huts were killed by each of the pirimiphos methyl CS
treatments. The formulation that killed more Cx. quinquefasciatus
(73%) than any other treatment was the 1.0 g/m2 application rate
of CS BM (p,0.01) (table 1). Pirimiphos methyl EC and
lambdacyhalothrin CS killed no more than 18% overall.
Huts with mud walls. Table 2 records the summary results
for An. gambiae and Cx. quinquefasciatus over 12 months in huts lined
with dried mud. The proportions of An. gambiae and Cx.
quinquefasciatus exiting the treated huts were not significantly
different from the proportions exiting the control hut. The
proportions blood-feeding in the insecticide treated huts were
not significantly different from proportions blood-feeding in the
untreated control (table 2).
The proportions of An. gambiae and Cx. quinquefasciatus killed in
the mud huts were less than the proportions killed in the cement
huts regardless of treatment. At the application rate of 1 g/m2 the
pirimiphos methyl CS B and BM variants performed equally well,
killing significantly more An. gambiae (75% and 76%) than did the
0.5 g/m2 rates of CS B (42%) or CS BM (52%) (p,0.001). The
pirimiphos methyl EC formulation killed only a small proportion
of An. gambiae (23%).
The trend in mortality for Cx. quinquefasciatus in the mud lined
huts mirrored that of An. gambiae. A slightly higher mortality rate
was observed with the 1 g/m2 pirimiphos methyl BM (51%) than
with the B (46%) variant (P = 0.04). The 1 g/m2 application rates
of these formulations killed more Cx. quinquefasciatus than the 0.5/
g2 rate (P = 0.001). With the pirimiphos methyl EC formulation,
only 15% of Culex was killed overall.
Residual Efficacy Against Free Flying Mosquitoes
Cement huts. Figures 1 and 2 show the monthly mortality
rates of An. gambiae and Cx. quinquefasciatus that freely entered the
cement walled huts during the course of the year.
The pirimiphos methyl CS BM formulation killed more than
80% of the An. gambiae per month for 9 months at the 1 g/m2
application rate and for 6 months at the 0.5 g/m2 rate, after which
mortality progressively declined (P,0.001) (figure 1). With the
pirimiphos methyl EC formulation percentage mortality was
highest during the first two months (.60%) but then decreased
suddenly. With the lambdacyhalothrin CS formulation the
mortality rate decreased to less than 20% within a month.
The trend in mortality for Cx. quinquefasciatus in the cement huts
was similar to An. gambiae, but the loss of activity against this
species was faster than against An. gambiae (p = 0.001) (figure 2).
Mortality rates with the pirimiphos-methyl CS treatments
exceeded 80% during the first month and remained higher than
60% after 6 months. With the pirimiphos-methyl EC treatment,
efficacy was lost within just a month. With the lambdacyhalothrin
CS treatment, efficacy was less than 20% after one month.
Mud huts. Figures 3 and 4 show the monthly mortality rates
of An. gambiae and Cx. quinquefasciatus in the mud lined huts over
one year.
The rate of treatment decay was faster in the mud walled huts
than in the cement walled huts (p,0.001). The 1 g/m2 application
rates of the pirimiphos methyl CS B and BM variants killed more
than 80% of An. gambiae per month for 4–5 months before showing
a progressive decrease in activity. Apart from an unusual drop in
mortality at month 8, which was observed with all formulations,
the 1 g/m2 pirimiphos methyl CS BM produced more than 70%
mortality per month for 10 months and the pirimiphos methyl B
produced more than 60% mortality per month for 9 months. The
difference in activity between the BM and B variants was more
evident with the 0.5 g/m2 application rate (figure 3).
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Only the 1.0 g/m2 application rate of pirimiphos methyl CS
produced high mortality of Cx. quinquefasciatus for 6 months or
longer (figure 4).
The pirimiphos methyl EC was only effective during the first
month of application, killing nearly 70% of An. gambiae and 40% of
Cx. quinquefasciatus before showing a sudden loss of activity.
The temporary drop in mortality around the 7–8th month
occurred at a time of year (November) when rainfall and humidity
were low and the temperatures were rising.
Species Characterization and Resistance Status
Only An. gambiae s.s. M form was found in the trial area. A
discriminating concentration of 1% pirimiphos methyl (i.e. double
Table 1. Summary results of indoor residual spray (IRS) treatments against An.gambiae and Cx. quinquefasciatus over 12 months in
cement lined experimental huts.
Cement huts Total collected
% Caught in Veranda
(CI) % Bloodfed (CI) % Mortality (CI)
% Corrected
Mortality
(CI)
Anopheles gambiae
Untreated 1286 42a (38–46) 89a (85–92) 10a (8–13) –
P-methyl CS B 0.5 g/m2 914 40a (36–44) 93b (91–95) 88b (82–91) 86 (80–89)
P-methyl CS BM 0.5 g/m2 964 40a (36–44) 95b (93–97) 92bc (88–94) 91 (87–93)
P-methyl CS B 1 g/m2 855 39a (35–43) 91ab (86–94) 90b (83–95) 89 (82–94)
P-methyl CS BM 1 g/m2 758 39a (35–44) 91ab (88–94) 95c (93–97) 94 (92–96)
P-methyl EC 1 g/m2 841 37a (32–43) 93b (89–96) 26d (21–32) 18 (13–24)
Lambdacyhalothrin CS 1149 64b (61–69) 93b (90–96) 22d (18–28) 13 (9–19)
Culex quinquefasciatus
Untreated 6178 39a (37–42) 69a (65–72) 9a (8–11) –
P-methyl CS B 0.5 g/m2 4661 35a (33–37) 78b (74–80) 56b (49–61) 51 (46–49)
P-methyl CS BM 0.5 g/m2 4544 38a (35–40) 74b (71–77) 66c (61–72) 64 (59–70)
P-methyl CS B 1 g/m2 4134 38a (35–40) 71a (67–75) 63c (56–69) 60 (53–66)
P-methyl CS BM 1 g/m2 4059 36a (34–39) 77b (73–80) 73d (68–77) 71 (66–75)
P-methyl EC 1 g/m2 3226 37a (34–40) 76b (72–79) 18e (15–21) 10 (7–9)
Lambdacyhalothrin CS 4699 40a (39–43) 73a (69–76) 13a (11–16) 5 (3–8)
Results in columns not sharing the same superscript are significantly different at the 5% level.
doi:10.1371/journal.pone.0069516.t001
Table 2. Summary results of indoor residual spray (IRS) treatments against An.gambiae and Cx. quinquefasciatus over 12 months in
mud lined experimental huts.
Mud hut Total collected % Caught in verandah (CI) % Bloodfed (CI) % Mortality (CI)
% Corrected
mortality
(CI)
Anopheles gambiae
Control 1270 42a (38–46) 89a (85–92) 10a (8–13) –
P-methyl CS B 0.5 g/m2 976 38a (34–42) 94b (92–96) 42b (37–49) 36 (31–43)
P-methyl CS BM 0.5 g/m2 882 37a (34–42) 95b (93–97) 54c (46–61) 48 (40–55)
P-methyl CS B 1 g/m2 670 38a (34–41) 97b (95–98) 75d (69–81) 72 (66–78)
P-methyl CS BM 1 g/m2 926 38a (33–43) 97b (95–98) 76d (68–83) 73 (65–80)
P-methyl EC 1 g/m2 663 39a (35–43) 95 (93–97) 23e (18–28) 14 (9–19)
Culex quinquefasciatus
Control 6145 39a (37–42) 69a (65–72) 9a (8–11) –
P-methyl CS B 0.5 g/m2 5178 37ab (35–40) 80b (76–83) 24b (21–27) 16 (13–19)
P-methyl CS BM 0.5 g/m2 4909 34b (32–36) 84b (82–86) 29c (26–33) 22 (19–26)
P-methyl CS B 1 g/m2 4797 33b (31–35) 85b (83–87) 46d (42–50) 40 (36–44)
P-methyl CS BM 1 g/m2 5419 34b (32–37) 83b (80–85) 51e (47–56) 46 (42–51)
P-methyl EC 1 g/m2 6046 36a (34–39) 81b (78–83) 15f (13–17) 7 (5–9)
Results in columns not sharing the same superscript are significantly different at the 5% level.
doi:10.1371/journal.pone.0069516.t002
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the LC100) was established using a range of concentrations against
the An. gambiae Kisumu strain (table 3). Using this discriminating
concentration against An. gambiae adults collected as larvae from
the trial site the mortality rate was 100% indicating no resistance.
In WHO susceptibility tests with 0.05% deltamethrin test papers
percentage mortality was 20% for An gambiae and 17% for Cx
quinquefasciatus (table 4). In molecular assays on An. gambiae the
frequency of kdr was 0.86 but no Ace.1R allele was detected. No
molecular assays were conducted on contemporary samples of Cx
quinquefasciatus but in an earlier characterization in the area the
frequency of kdr was 0.63 and the frequency of Ace.1R was 0.03
[23].
Residual Bioassay Activity
Figure 5 and 6 show the results of residual bioassay tests
conducted with the susceptible An. gambiae Kisumu strain on
insecticide treated cement and mud wall surfaces.
On cement surfaces the BM CS variant killed more than 80%
throughout the 4 quarters. The B CS variant killed more than
80% during the first three quarters but by the fourth quarter
Figure 1. Monthly mortality rates of Anopheles gambiae in experimental huts lined with cement plastered walls.
doi:10.1371/journal.pone.0069516.g001
Figure 2. Monthly mortality rates of Culex quinquefasciatus in experimental huts lined with cement plastered walls.
doi:10.1371/journal.pone.0069516.g002
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mortality had decreased to 60% (figure 5). The EC formulation
produced a faster decline in activity with mortality decreasing from
100% to 40% after the first quarter (P,0.001). The lambdacy-
halothrin treatment was highly active on cement for 6 months,
showing 75% mortality of susceptible An. gambiae during the
second quarter; this contrasts with a low mortality rate over the
same period against free flying wild An. gambiae in the
lambdacyhalothrin hut.
The residual activity of all treatments on mud walls was high
initially (100% mortality in the first quarter) but decreased steadily
over time (figure 6). A decrease of B and BM activity was evident
during the second quarter for the lower dosage and during the
Figure 3. Monthly mortality rates of Anopheles gambiae in experimental huts lined with mud plastered walls.
doi:10.1371/journal.pone.0069516.g003
Figure 4. Monthly mortality rates of Culex quinquefasciatus in experimental huts lined with mud plastered walls.
doi:10.1371/journal.pone.0069516.g004
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third quarter for the higher dosage (p,0.001). The EC was
ineffective by the second quarter.
Responses of Sleepers to the Treatments
All odour due to treatment began to fade within a day of
spraying and after 6 days no odour was reported by sleepers for
any treatment. Odour was dosage dependent and all volunteers
agreed that pirimiphos methyl EC produced the strongest odour.
Odour evoked a variety of responses from good to unpleasant but
strong odour was not always deemed negatively but as indicating a
good product.
Discussion
With impetus from governments, the Global Fund and
President’s Malaria Initiative, IRS is being deployed in 31 African
countries in the attempt to reduce malaria burdens across Africa
[1]. Of the four classes of insecticide currently available for IRS,
the cheapest, DDT, is compromised by its negative environmental
impact, and the most widely used, the pyrethroids, threaten to
accelerate the selection of resistance and undermine long lasting
insecticidal nets [21–22,31]. The WHO is recommending
switching from IRS with pyrethroid in any country where LLINs
are widely used in order to sustain the operational life of the LLIN
strategy [32]. There is an urgent need to find alternative
insecticides to pyrethroids and DDT in order to maintain the
two pronged attack of IRS and LLIN against malaria while
simultaneously reducing the selection pressure for pyrethroid
resistance. The President’s Malaria Initiative is using the
carbamate bendiocarb for IRS in countries where pyrethroid
resistance is prevalent [4–5,33–35]. The problem with carbamate
insecticides is their short residual life, which means having to spray
twice per year in countries where malaria transmission seasons are
longer than the 2–3 month residual lifespan of the carbamate, as
occurs in many sub-Saharan countries [36–37]. Short residual life
is a problem shared with the fourth group of insecticides used for
IRS, the organophosphates. As shown in the present study,
standard EC formulations of organophosphates will last for 2–3
months at best and this restricts their deployment by national
malaria control programmes [2]. Microencapsulation of organo-
phosphates minimizes that limitation. Residual activity is extended
for up to 10 months on cement walled surfaces and for 6–8 months
on mud walled surfaces, which is sufficient to cover the longest
transmission season or even the twice yearly transmission seasons
that occur in East Africa [31,38]. While an application rate of
0.5 g/m2 might be sufficient in more modern housing which have
cement walls, an application rate of 1.0 g/m2 would be necessary
in rural villages where mud lined walls are standard.
The microencapsulation technology that enabled the develop-
ment of lambdacyhalothrin CS, a long lasting pyrethroid
formulation, provided the stimulus for Syngenta’s development
and re-formulation of the organophosphate pirimiphos methyl.
The evolution of resistance, as shown in the present hut trial with
pyrethroid IRS, can undermine the residual life that encapsulation
would otherwise bring to a compound. Lambdacyhalothrin CS
has a residual life of at least 6 months on cement surfaces, as
shown in bioassays with susceptible mosquitoes, but once wild
mosquitoes become highly resistant to pyrethroids, the duration of
protection may be reduced to a month or less, despite surface
residues persisting for much longer.
In such conditions only an insecticide that shows no cross
resistance to pyrethroids, such as an organophosphate or
carbamate, can be deployed to good effect [4,24,37]. The longer
the residual activity the better the cost-benefit. Recurrent malaria
control campaigns over 3 years with the carbamate, bendiocarb, in
Benin had a significant impact on transmission by the malaria
vector An gambiae which was pyrethroid resistant [4,34]. However,
in a community randomized trial that compared the combined
impact of bendiocarb IRS plus LLINs against LLINs alone, the
bendiocarb IRS showed no additional impact over LLINs alone
[39]. After an IRS campaign with bendiocarb on Bioko island in
Equatorial Guinea, the prevalence of malaria started to increase
3–5 months after spraying as bendiocarb residues decayed [36].
Microencapsulated IRS products with longer residual activity than
bendiocarb have the potential to control malaria over an entire
Table 3. Determination of diagnostic concentration of pirimiphos methyl in silicon oil in WHO susceptibility tests. Mosquitoes
were exposed for 1 h and mortality recorded 24 h later.
Strain % Concentration Number tested % Mortality
Anopheles gambiae Akron (F1 of wild population) 0 71 0
0.125 83 9
0.25 94 58
0.50 90 100
1.0 92 100
Anopheles gambiae Kisumu (laboratory susceptible strain) 0 72 0
0.125 89 18
0.25 73 99
0.50 93 100
1.0 95 100
doi:10.1371/journal.pone.0069516.t003
Table 4. Susceptibility of wild Anopheles gambiae and Culex
quinquefasciatus from field station Akron to pyrethroids.
Species Number tested % Mortality
Culex quinquefasciatus 96 17
Anopheles gambiae 80 20
F1 adults were exposed to 0.05% deltamethrin test papers for 1 h and mortality
recorded 24 h later.
doi:10.1371/journal.pone.0069516.t004
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transmission season while covering any break in control resulting
from shorter lived insecticides.
Providing universal coverage of LLINs to populations at risk has
become a priority for many national malaria control programmes
in recent years [1]. Pyrethroid resistant Anophelines are now
present in all African countries, and the frequency of resistance is
increasing due to selection pressure from LLINs and pyrethroid
IRS [12–17]. LLINs can still provide personal protection
particularly when the netting is intact [40]. With the increasing
coverage of LLINs in many endemic countries the deployment of
IRS using pirimiphos methyl CS will usually be done against a
background of LLIN coverage. Case control studies have shown
Figure 5. Residual activity of IRS in experimental huts lined with cement plastered walls using WHO cone bioassays and insecticide
susceptible Anopheles gambiae Kisumu strain.
doi:10.1371/journal.pone.0069516.g005
Figure 6. Residual activity of IRS in experimental huts lined with mud plastered walls using WHO cone bioassays and insecticide
susceptible Anopheles gambiae Kisumu strain.
doi:10.1371/journal.pone.0069516.g006
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that a combined intervention of organophosphate IRS and
pyrethroid treated net provides added protection against malaria
infection [41]. Recent trials of the combination intervention of
LLINs and pirimiphos methyl CS in experimental huts against
pyrethroid resistant An gambiae support that inference (Ngufor &
Rowland, unpublished).
In some countries where extra resources for malaria control
have become available, programmes are deploying both IRS and
LLIN in areas of high transmission. There is some evidence that
the combined approach can potentially provide greater protection
or reduce transmission faster than one method alone [40,42]. The
combined use of organophosphate IRS and LLINs, through the
deployment of two classes of insecticide with alternative modes of
action has the potential to reduce selection pressure for resistance
[32]. Pyrethroid resistant mosquitoes that come into contact with
IRS surfaces should be killed by the organophosphate. The spatial
combination of pirimiphos methyl CS and LLINs within homes
may help to keep malaria control and elimination targets on track.
Whether the combination intervention will delay the selection of
resistance is less certain and will depend in part on the initial
frequency of each type of resistance.
Limited environmental persistence and long residual activity
makes pirimiphos methyl CS a more attractive prospect than
DDT for IRS programmes [43]. There is a need to accelerate the
development, registration and global access to pirimiphos methyl
CS. Any hope or plan for sustained control or indeed elimination
of malaria in sub Saharan Africa will depend on continued
investment and development of long lasting insecticides for vector
control.
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